An exhibition showing how charity donations are supporting medical research has launched in Leeds. Our Research Story celebrates eight early career researchers who have been able to lead studies ...
Former Mauritian Prime Minister Pravind Jugnauth has been released on bail following his arrest on Sunday on money laundering charges. He was taken into custody following searches by ...
Regeneron Pharmaceuticals (NASDAQ:REGN) is one of the leaders in the ophthalmic disease therapeutics market. In this article, dear Seeking Alpha readers, I present five factors that explain why I ...
A modern art exhibition on display in the west of the Isle of Man aims to explore different perspectives of the Manx landscape. Six 'ways of seeing' at the House of Manannan in Peel features the ...
A Christian advocacy group is praising God for “victory” after successfully working to shut down what they say is a “disturbing exhibit” at a Texas museum. The Danbury Institute, a nonpartisan ...
A unique polling booth in Delhi, themed 'Chandrayan se chunav tak Bharat ki udaan,' features models of Chandrayaan and PSLV along with telescopes and VR equipment. The booth, decorated with ...
MLB The Show 25's gameplay trailer showcases new features, including improved visuals and revamped modes. The game includes an expanded Road to the Show mode, new animations for realism ...
SAN FRANCISCO, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals ... views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure ...
EyePoint Pharmaceuticals, a biotech attempting to grab a sliver of Regeneron’s share of the degenerative eye disease market, said six-month results show its ...
Regeneron Pharmaceuticals ... becoming the first immunotherapy to show a benefit in this high risk population. At the first pre-specified interim analysis for disease free survival, adjuvant ...
Regeneron reported Q4 earnings on Tuesday, with revenues up 10% versus Q4 in 2023. EYLEA HD has stabilized its franchise with a modest sales growth of 1% in 2024 versus 2023. Biosimilar ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results